Cassidy Is Circulating a Proposed Law to Push Down U.S. Drug Prices, Backing a Key Trump Ambition

Cassidy is circulating a proposed law to push down U.S. drug prices, backing a key Trump ambition

Cassidy's proposal to lower U.S. drug prices offers support to one of President Trump's major ambitions.

Senator Cassidy Report Reveals Billions in Revenue Flow Through 340B Drug Pricing Program

Senator Bill Cassidy, chair of the Senate Committee on […] The post Senator Cassidy Report Reveals Billions in Revenue Flow Through 340B Drug Pricing Program first appeared on GeneOnline News. The post Senator Cassidy Report Reveals Billions in Revenue Flow Through 340B Drug Pricing Program appeared first on GeneOnline News.

Cassidy Staffer, ASAP 340B Head Call for 340B Program Reforms, Comment on Proposed Shift to CMS - 340B Report

A key health policy staffer for U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Bill Cassidy (R-La.) recently joined 340B critics in calling for major program reforms based on the senator’s investigation into the pricing program—noting how they could align with drugmakers’ proposed 340B rebate models and a potential U.S. Department of Health and Human Services (HHS) shakeup.